Image: Deputy Director of Burnet Institute and Head of the Anderson Diagnostics Development Laboratory, Associate Professor David Anderson is leading this innovative development along with Dr Michelle Scoullar.
Voting is now open for the People’s Choice Award!
The Saving Lives at Birth, finalists including Burnet Institute are competing for the coveted People’s Choice Award. We are in the last 50 Round 6 finalists, from a world-wide pool of 650 applications.
Going Against the Flow: Diagnosis of Neonatal Sepsis at the Point-of-Care
Burnet will develop a simple, lateral-flow point of care test that can identify white blood cell changes that have been well-validated as markers of neonatal sepsis, but have previously required complicated flow cytometry for evaluation. This technology development will facilitate future manufacture and worldwide distribution of a validated test to reduce death and disability from neonatal sepsis. The objective and end point is a validated test that can be transferred to manufacture and clinical trials for maximum impact. By using a well-validated marker, but making it available to frontline healthcare workers, we will have the maximum impact on this major cause of infant mortality and disability.
The Saving Lives at Birth DevelopmentXChange is underway in Washington, D.C. The gathering brings together global problem-solvers, entrepreneurs, scientists, and innovators to develop and scale their transformational solutions to improve maternal and newborn survival and address the needs of the poorest and hardest-to-reach communities around the world.